title: Phase I trials in oncology: a new era has started.
authors.affiliation: Department of Drug Development, Gustave Roussy Cancer Campus, Villejuif; South Paris University, Orsay, France.
authors.forename: S
authors.initials: S
authors.lastname: Postel-Vinay
authors.affiliation: Department of Drug Development, Gustave Roussy Cancer Campus, Villejuif; South Paris University, Orsay, France. Electronic address: jean-charles.soria@gustaveroussy.fr.
authors.forename: J-C
authors.initials: JC
authors.lastname: Soria
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D000077547:Crizotinib; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D000077547:Crizotinib